Unither Pharmaceuticals is a Global Development and Manufacturing partner for proprietary and generic dosage forms and a global leader in single unit dosage forms, specializing in Blow-Fill-Seal (BFS), but also: preservative-free multidose, oral liquid forms (liquid sick-packs, bottles) and solid dosage forms (suppositories, pessaries, tablets & capsules). Our technologies enable line extensions and product differentiation that support modern on-the-go lifestyles, with the potential to improve dosing safety and medication adherence. Our mission is to provide innovative, competitive, and sustainable solutions to our customers. Founded in France in 1993, Unither Pharmaceuticals has grown to employ 1500 people around the world and now has R&D and manufacturing sites in Europe, North America and Brazil, and China.
Unither Pharmaceuticals uses Blow-Fill-Seal (BFS) and liquid stick-pack technologies to produce small to medium-volume liquid or semi-solid filled and sterile unit doses. We are a worldwide leader in this area, selling 3,6 billion BFS doses and 500 million liquid stick-packs in over 100 countries annually. Our other production capabilities include preservative-free multidose, oral liquid bottles, and solid dosage forms (suppositories, pessaries, tablets & capsules), and extended release products. In addition to providing manufacturing services, Unither offers expertise in strategic outsourcing, regulatory affairs and R&D, particularly in formulation development for innovative dosage forms. Unither Pharmaceuticals is the global leader in sterile unit-dose contract manufacturing. Unither Pharmaceutical Technologies is based in Wuhan and provides regulatory affairs and R&D services to our customers.
